Skip to Content

Brincidofovir Approval Status

  • FDA approved: No
  • Generic name: brincidofovir
  • Company: Chimerix, Inc.
  • Treatment for: Ebola Virus Disease

Brincidofovir is a nucleotide analog broad-spectrum antiviral under FDA review to assess the safety and efficacy in patients with confirmed Ebola virus infection.

Development Status and FDA Approval Process for brincidofovir

DateArticle
Nov 13, 2014Chimerix's Brincidofovir Selected for Use in Ebola Clinical Trial in West Africa
Oct  6, 2014Chimerix Announces Emergency Investigational NDA for Brincidofovir Authorized by FDA for Patients With Ebola Virus Disease

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide